Pfizer revenue for the last year amounted to 58.50 B USD, the most of which — 57.19 B USD — came from its highest performing source at the moment, Biopharma, the year earlier bringing 98.99 B USD. The greatest contribution to the revenue figure was made by United States — last year it brought Pfizer 27.09 B USD, and the year before that — 42.47 B USD.